Nevertheless, numerous studies have found a positive association between tumor CD69+CD103+T-cell infiltration and clinical outcomes, suggesting the beneficial role of this immune cell population in restricting tumor development and therapeutic responses86,88,94–98. The gene discussed is CD69; the disease is neoplasm.